Immune Checkpoint Inhibitor–Based Combinations for Patients With NSCLC and Acquired Resistance to Immunotherapy

Review the latest clinical data on novel approaches to extend the benefits of immunotherapy after disease progression in advanced NSCLC with downloadable slides and an interactive webcast from a live, expert-led roundtable webinar.

Share

Program Content

Activities

ICI Combos in IO-Pretreated NSCLC
Immune Checkpoint Inhibitor–Based Combinations for Patients With NSCLC and Acquired Resistance to Immunotherapy
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 06, 2023

Expires: December 05, 2024

Activities

Immune checkpoint inhibitors for NSCLC
Immune Checkpoint Inhibitor–Based Combinations for Patients With NSCLC and Acquired Resistance to Immunotherapy
Video
Congratulations: You achieved a completion on 04/09/2022

Released: December 11, 2023

Expires: December 10, 2024

Faculty

cover img faculity

Christine M. Bestvina, MD

Assistant Professor
Section of Hematology/Oncology
Division of Medicine
University of Chicago Medicine
Chicago, Illinois

cover img faculity

Karen Reckamp, MD, MS

Director, Division of Medical Oncology
Associate Director, Clinical Research
Professor, Department of Medicine
Cedars-Sinai Medical Center
Los Angeles, California

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Lilly.

Lilly